Correlation of gallium-68 prostate-specific membrane antigen positron emission tomography – Computed tomography/magnetic resonance imaging with histopathology characteristics in carcinoma prostate patients undergoing radical prostatectomy
Introduction: Gallium-68 prostate-specific membrane antigen positron emission tomography (68Ga-PSMA PET) is being increasingly used in patients with prostate cancer (PCa) for the staging and detection of lymph node (LN) metastases, despite a lack of prospective, validated evidence. We aimed to inves...
Saved in:
| Main Authors: | P Taur Pratik, Deerush Kannan Sakthivel, S Tiwari Madhav, P Bafna Sandeep, Narasimhan Ragavan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-01-01
|
| Series: | Indian Journal of Urology |
| Online Access: | https://journals.lww.com/10.4103/iju.iju_143_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gallium-68 prostate-specific membrane antigen positron emission tomography/computed tomography compared with diagnostic computed tomography in relapsed prostate cancer
by: Marcus Edward Asokendaran, et al.
Published: (2019-07-01) -
Oligometastasis to testis in prostate cancer: Role of gallium-68 prostate-specific membrane antigen positron-emission tomography computed tomography
by: Manoj Gupta, et al.
Published: (2021-03-01) -
A case of well-differentiated hepatocellular carcinoma identified on gallium-68 prostate-specific membrane antigen positron emission tomography/computed tomography
by: Hian Huang, et al.
Published: (2018-04-01) -
False-positive prostate cancer bone metastases on magnetic resonance imaging correctly classified on gallium-68-prostate-specific membrane antigen positron emission tomography computed tomography
by: Sofiullah Abubakar, et al.
Published: (2018-10-01) -
Neuroendocrine prostate cancer or prostatitis? An unusual false positive on gallium-68 DOTA-Tyr3-octreotate positron emission tomography/computed tomography in a patient with known metastatic neuroendocrine tumor
by: Matthew Q Schmidt, et al.
Published: (2019-07-01)